chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received vaccine from Employee Health few hours after receiving vaccine pt c/o "itchy back" - raised red rash over entire torso - resolved within 12 hours.
PT's mother said PT had a seizure in the evening, took daughter to hospital. Called office next day.
Broke out in itchy hives all over her body and also developed a very hoarse cough which turned into a congested cough. My daughter STILL has the hives and cough and the date is now 10/15/2015. Her doctor insists this is not from the vaccine. Of course, myself and my husband do not agree. We have also noticed behavioral changes (throwing tantrums which is very out of character for her) and also tactile dysfunction particularly pertaining to her clothing.
Fifteen minutes post vaccine patient started to feel itchy on her arms, with noted erythema.  Given PO diphenhydramine x 1 dose
Arm red, swollen and can't move it.   It looks like cellulitis.  Pt. feels like with virus symptoms.
Pain in arms, hands, shoulders, neck, head, legs, feet. Constant sore throat, blood pressure spike, eczema, fatigue, flushing, weakness, malaise, headache, insomnia, migraine, neuropathy, muscle weakness.
got my 2nd shingles shot at 7:45 am and at 8:00 pm I got the Chills and hour or so later I was throwing up, threw up 3 times and  the chills lasted till about midnight 1:00 am
Dizziness, Headache, Myalgia, Arthralgia, Fever, NauseaVomiting, Tachycardia,  Lymphadenopathy under armpit of injection site and  fatigue  Narrative: Patient self-medicated with Tylenol and motrin
expired vaccine administered to 14 patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine administered to 14 patients) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine administered to 14 patients). On 12-Oct-2021, EXPIRED PRODUCT ADMINISTERED (expired vaccine administered to 14 patients) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were provided.
I received the vaccine on 1/15/21. I was 12 weeks and 4 days pregnant. My cell free DNA testing was normal that week and it was a boy. My ultrasound 4 days prior was normal too. On 1/19/21 the baby did not have a heartbeat. My EDD was 7/26/21
On 15 Mar 04 @ 2000 arms started aching and had small red spot where shot was given. 16 Mar 04 red was from shoulder past elbow and arm had swollen alot. Dr put me on Cephalexin and Ibuprofen for 10 days.
8 hours after receiving, began vomitting for about 3 hours.  after 13 hours, began a fever of 103.4. Body HURT so bad. I started taking tylenol and EVERY 3 hours fever returned. Fever went on for 2 days before I could go a little longer on the tylenol. 4th day my injection site had a giant lump that stuck up about an inch. It had a constant fever of 101 and was bright red and itchy. The fever of the bump was not changed at all by the tylenol. About the 5th day when the fever was getting better I started getting terrible headache. The headache lasted about a week.
This spontaneous case was reported by a consumer and describes the occurrence of DISORIENTATION (disoriented), HYPOAESTHESIA (had a numbness on the left side at her temple), TACHYCARDIA (a rapid heartbeat), TREMOR (uncontrollable body tremoring) and DRY MOUTH (dry mouth) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced DISORIENTATION (disoriented), HYPOAESTHESIA (had a numbness on the left side at her temple), TACHYCARDIA (a rapid heartbeat), TREMOR (uncontrollable body tremoring), DRY MOUTH (dry mouth) and FEELING ABNORMAL (brain fog). On 12-Feb-2021, DISORIENTATION (disoriented), HYPOAESTHESIA (had a numbness on the left side at her temple), TACHYCARDIA (a rapid heartbeat), TREMOR (uncontrollable body tremoring), DRY MOUTH (dry mouth) and FEELING ABNORMAL (brain fog) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Patient was given the Moderna vaccine. Patient's age was 17 at the time of the vaccine.
From telephone contact with reporting physician it was stated that a 5 month old male patient received an IPOL, a Tripedia, a Hibtiter, and a prevnar vaccination on 7/23/01. On 7/24/01 the patient developed a local reaction of redness, swelling and irritability. Patient was treated with Ibuprofen.
This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. The patient's pertinent medical history, allergic reactions and concomitant medications were unspecified. On 27-JUL-2016, the patient was vaccinated with an improperly stored dose of VARIVAX (lot # M000996, expiry date 07-JAN-2018, dose, strength, vaccination site, route unspecified). The vaccine was exposed to a temperature of 6.5 Fahrenheit (F) for 80 hours. Digital data logger was not involved. There were no previous temperature excursions. No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
6/23/06 tetanus shot given. 6/28-29 sore neck muscles rt side. 6/20 sore neck muscles rt side, lips numb, rt eye won't blink or close, right side of mouth drooping, rt nostril closed. 7/05/06 Prednisone various amounts until 7/07/06. 7/07/06 Azithromax 5 pack for sinus congestion and heavy chest. Eye ointment for dry eyes. 7/07 back muscle spasms. 7/10 series of back muscle spasms. 7/10 series of back muscle spasms.
Patient was S/P cycle 3 day 4 on 10/23/2008.  On 10/26/2008, patient went to hospital emergency room with chills, rigors, and SOB.  Patient chest x-rays on 10/26/2008 showed bibasilar pneumonia.  During the hospitalization, patient was treated with Zosyn, Azithromycin, Linezolid, and Tamiflu.  Patient was discharged from hospital on 10/30/2008. 12/29/08-records received for DOS 10/26-10/30/08-DC DX:Bilateral infiltrates likely pneumonia. Sudden onset of cough and collapsed, loss of consciousness.
CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; This spontaneous report received from a patient via other company(pfizer) concerned a 38 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: allergy. The patient received covid-19 vaccine ad26.cov2.s (dose number in series: 1) (suspension for injection, route of admin not reported, batch number: 1808982 expiry: UNKNOWN) dose was not reported, 1 total administered to left arm on 10-APR-2021 for covid-19 prophylaxis. Age at time of vaccination 37 years old. Concomitant medications included bupropion, dexmethylphenidate, ibuprofen, loperamide, and simeticone for drug used for unknown indication. The patient received Non-company suspect vaccine elasomeran (Moderna) (dose number in series: 2) (form of admin, route of admin, and were not reported) dose was not reported, batch number: 939903 expiry: UNKNOWN, dose 2, administered to left arm on 26-OCT-2021 for covid-19 prophylaxis. On 29-JUL-2022, the patient was treated with non-company suspect drug Paxlovid (route of administration, batch number and expiry were not reported) dose and frequency were not reported for covid-19 treatment and last administered on 02-AUG-2022.  On 05-AUG-2022 and 06-AUG-2022, Laboratory data included: COVID-19 PCR test Negative. On 08-AUG-2022, the patient experienced return of mild fever, congestion, sore throat, diarrhea (confirmed covid-19 infection) (dose number in series: 2). Symptoms milder than original infection and so far do not include the joint pain and chills (dose number in series:2). On 09-AUG-2022, the patient tested positive for covid-19 virus test (confirmed clinical vaccination failure) (dose number in series: 1). The action taken with covid-19 vaccine ad26.cov2.s and elasomeran was not applicable, paxlovid was drug discontinued. The patient had not recovered from confirmed covid-19 infection, and the outcome of confirmed clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with a product quality complaint: 90000246766.; Sender's Comments: V0- 20220832710 -COVID-19 VACCINE Ad26.COV2.S- Confirmed clinical vaccination failure. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS. Therefore, this event(s) is considered not related.
Client went on Sunday, March 11, 2007 complaining of headache, nausea and vomiting since Saturday, March 10, 2007.
Around 04:00PM after my 2nd dose, I started having muscle aches, chills, fever, and headache. These symptoms lasted 3 days.
Loss of taste Narrative: Has acrid taste in his mouth which he experienced with COVID early November 2020
She got flu/cold-like  symptoms for 1 month and then after she got lots on flu-like symptoms last for 2.5 months. Her immune system was very weak. This happen right after she received her pediatrix shot. Doctor did an environmental allegy test and she was normal and other tests and the doctor could not explain what was wrong with her.
This spontaneous report was received from a Registered nurse regarding a 14 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 26-APR-2018, the patient was vaccinated with improperly stored dose of GARDASIL 9 lot# N004798 with expiration date: 31-OCT-2019 (dosing details and route of administration was not reported) for prophylaxis. No adverse effects were reported. The storage temperature was 47 degrees Fahrenheit to 77 degrees Fahrenheit (49F) and time frame was 14 hours. There was no previous temperature excursion. Digital data logger was involved. No product quality complaint was involved. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1804USA005153.
2ND Pfizer covid-19 vaccine administration 1/14/2021. Patient symptom onset 3/16/2021 - headache, 3/21/2021 - rash diagnosed to be herpes zoster V1/V2 distribution, 4/12/2021 - herpes zoster ocular involvement with scratchiness, visual halos and decreased visual acuity of 3 days duration.
Severe Chest pain radiating to back.  lasting approx 30 minutes.    approx 6 hours later, pt experienced severe lumbar back pain with bilateral leg pain, headache, nausea and weakness. Weakness and fatigue continued.
The day of vaccination, patient had soreness in the arm.  Then overnight, patient woke up with body aches and chills but was able to fall back asleep, Then the following day, and into the evening, started feeling like she could not get out of bed, severe weakness, dizzy, and lightheaded with vision changes "like prisms" when attempting to get up.   Was advised to go to the ED where she had Tmax 101, pulse 110 that improved to 70s after IV fluids, blood pressure stable.  Admitted 09/26/2021 and discharged 09/28/2021.  While hospitalized developed severe leg pain, right hand tremor and intermittent blurred vision.  Patient had another flare up of severe leg pain  10/18/2021 that led to another hospitalization for pain control and neuro work up, discharged 10/23/2021.  Diagnosed as neuropathy without otherwise clear cause at this time.
ADMINISTERED EXPIRED VACCINE THAT HAD REACHED TWO HOUR LIMIT; This spontaneous report received from a health care professional concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced administered expired vaccine that had reached two hour limit. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administered expired vaccine that had reached two hour limit was not reported. This report was non-serious.
Complaint of pain, fever, left leg induration, erythema, increased heat and tenderness on left lateral thigh.
Dry cough; Headache; Very mild runny nose; Body aches; Chills at 3:00am and other random; This is a spontaneous report received from a contactable consumer or other non hcp. A 33-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number was not reported) via an unspecified route of administration in Arm Left on 05Feb2021 04:30 (age at vaccination 33years old) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient did not have known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication(s) included elderberry [sambucus nigra] (ELDERBERRY [SAMBUCUS NIGRA]) taken for an unspecified indication, start and stop date were not reported. Since the vaccination, the patient had not been tested positive for COVID-19. The patient experienced that on 12Feb2021 20:00 he had dry cough, headache, very mild runny nose, body aches, chills. The patient did not receive any treatment for the adverse events. The clinical outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Heart pounded, chills, sweats, nausea, aches, shaky,  muscle weakness, shortness of breath, felt like someone was squeezing my upper body, increased blood pressure. Started first night, heart pounding lessened over next few days. Five days after injection heart wouldn't quit pounding. Went to ER
PRIOR TO FIRST DOSE I WAS STRONG. I COMPLETED A 240 MILE HIKE IN RECORD TIME. 2 DAYS AFTER FIRST DOSE I EXPERIENCED TROUBLE BREATHING AND FATIGUE. I THOUGHT THIS WAS NORMAL SIDE EFFECT. I COULD NOT WALK AROUND THE BLOCK WITHOUT RUNNING OUT OF BREATH. SYMPTOMS LASTED AN ENTIRE MONTH. AFTER SECOND DOSE, THE VACCINE CLINIC RECOMMENDED I CALL MY DOCTOR. DOCTOR ADVISED I GO TO ER. 2 DAYS LATER, I GO TO ER. I STAY IN ER FOR 3 DAYS WHILE THEY RUN TESTS. I AM DISCHARGED ON 3/9/21. COINCIDENTALLY, THAT WAS WHEN CHEST PAINS STARTED. I HAVE HAD CHEST PAINS EVER SINCE. I HAVE VISITED DOCTORS, AND HAVE TAKEN TESTS, AND HAVE BEEN DIAGNOSED WITH PERICARDITIS. I AM NOW TAKING COLCHICENE WITH IBUPROFIN
down for 3 days; This spontaneous case was reported by a consumer and describes the occurrence of DEPRESSED MOOD (down for 3 days) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033H21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Flu shot (Has not gotten since. Bad reaction and stayed home for days and wasn't feeling well.) in 2005. Past adverse reactions to the above products included Sickness with Flu shot. Concurrent medical conditions included Diabetes, Hypertension, Hypercholesterolaemia, Drug allergy (Cannot use hydrocodone and depo - had reaction many years ago.) and Food allergy (Food and other products). Concomitant products included ATORVASTATIN for Hypercholesterolaemia, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN/HYDROCHLOORTHIAZIDE) for Hypertension.    On 06-Jan-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2022, the patient experienced DEPRESSED MOOD (down for 3 days). The patient was treated with MELATONIN at a dose of 5 milligram, softgel before bedtime. In January 2022, DEPRESSED MOOD (down for 3 days) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Other concomitant medication include GARDANCE 10mg once a day for diabetes.   This case was linked to MOD-2022-483426 (Patient Link).
Hospitalized (3.27.22);  COVID-19 positive (3.27.22);  fully vaccinated PLUS booster BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider at Discharge: PA-C   Admission Date: 3/27/2022 Discharge Date: 3/28/2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 85 y.o. male who presented to emergency department with complaints of generalized weakness and a cough.  Patient has past medical history of type 2 diabetes, Parkinson's disease, hypertension, hyperlipidemia, anemia, CKD stage III, and urinary retention.Patient has complaints of generalized weakness and new onset cough.  He has been unable to perform routine ADLs and his spouse has had difficulty helping him.  Patient presented to the emergency department for further evaluation.  In the emergency department, patient was tachycardic, tachypneic, hypertensive, but did not require supplemental oxygen.  Lab results were significant for leukocytosis.  Lactic acid was 2.5, however, procalcitonin was negative.  COVID-19 was positive.  Chest x-ray demonstrated some streaky opacification within the lingula reflecting atelectasis or early/developing pneumonia.  Suspect COVID-19 with pneumonia developing.  Patient has been admitted for further evaluation and management of generalized weakness secondary to COVID-19.   Patient remained afebrile and stable on room air.  Repeat magnesium level showed magnesium replete.  He received a dose of IV Rocephin and doxycycline for presumed pneumonia given chest x-ray, slightly elevated lactic acid under admission and leukocytosis.  PT OT evaluated patient and recommended home with assist, home health PT OT.  Patient's wife also at bedside and educated on call with med adjustment at home and quarantine.  Patient has a follow-up appointment with his PCP on 04/07/2022 at 8:45 a.m..  He was given a 6 day prescription of doxycycline and Ceftin to finish remaining course of treatment for pneumonia.  All questions and concerns were addressed prior to discharge.
Soreness, pain at injection site, low stamina, vertigo, tiredness. Has a history of middle ear problems and vertigo but felt got much worse after TD on 12/7/00.
Pt. developed rash after vaccines were given.  I'm sure of due to Varivax n MMR.
"my arm (left) hurts and there is some redness.  .3cm erythema distal and medial to injection site. Warm to touch.
Nothing heart till the next morning . Arm felt absolutely sore like I fell down stairs. Bruised injection site formed and kind of went blackish stayed for 3 weeks. Left hand gets cold . Heart has been feeling tight and races and it feels like I have something in the back of my throat that I can't swallow,  makes me cough sometimes.
Headache, Myalgia, fatigue, pain and lump at the injection site Narrative:  fatigue, body ache and headache lasted 24 hours injection site pain and lump lasted 6 days  Other Relevant History:
Painful psoriasis lesions.  No psorias outbreak since 2008.  Was able to get back under control with diet but was  evaluated by dermatology 9/21 for lesions that would not and still not resolved despite dermatology percribed cream.  Lesions are pain and mostly hinder sleep.   Painful upper body joints, with intermitting numbness from right elbow to right hand, still ongoing.  Been evaluated for lymes evaluated by Ortho for ligament or muscle involvment, attempted steroid injections without relief.   Had physical therapy.   Now, being evaluated by Rheumatology.   Registered Nurse, being advised to get booster by employer despite still experiencing symptoms from 2nd dose without an explanation from providers.
Headache, muscle soreness, joint pain, fever, chills, cold sweats, loss of taste, stuffy nose, dry cough
Tingling; Loss of sensation; Pain; Distal chilblains on two right toes; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the arm left on 28Mar2021 at 00:15(at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, asthma, anemia, epstein-barr viremia, depression, migraine, migraine, chronic pain and sulfonamide allergy. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN), cetirizine (MANUFACTURER UNKNOWN), iron (MANUFACTURER UNKNOWN), desvenlafaxine (MANUFACTURER UNKNOWN)and vitamin d nos (MANUFACTURER UNKNOWN) all from unknown date and unknown indication. The patient previously took Amoxicillin and Azithromycin a experienced allergy. Prior to the vaccination, the patient  was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 the patient experienced Tingling, Loss of sensation, Pain and Distal chilblains on two right toes. The patient did not receive any treatment for the event. The clinical outcome of the event Tingling was not resolved. The clinical outcome of the event Loss of sensation was not resolved. The clinical outcome of the event Pain was not resolved. The clinical outcome of the event Distal chilblains on two right toes was not resolved.   No follow-up attempts are needed. No further information is expected.
5 months after 2nd dose, I had mild symptom of pericarditis that lasted about 3 hours.  Mild, constant sharp pain on left side of chest while inhaling.  Took acetaminophen and pain subsided and did not reoccur.  Self-diagnosed and treated.
4 x 4 cm indurated erythematous area to injection site at (RT) outer thigh.
Chest pain; Fatigue; Shortness of breath; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0217) via an unspecified route of administration in the left arm on 04Jun2021 at 18:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0168) via an unspecified route of administration in the left arm on 11May2021 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. On 11Jun2021, the patient experienced chest pain, fatigue and shortness of breath. The events resulted in emergency room/department visit or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chest pain, fatigue and shortness of breath was resolved on an unknown date in 2021.  No follow-up attempts are possible. No further information is expected.
The pt experienced diarrhea, sensitive to sound, hyperactivity, speech stopped, lost eye contact, became withdrawn, and autism. The 60 day follow up states diagnosis of autism unchanged.